# FDA Inspection 1218140 - Advarra IRB - September 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/advarra-irb/210a0bd8-1eb7-4446-b84b-cfff242bb2fb
Source feed: FDA_Inspections

> FDA Inspection 1218140 for Advarra IRB on September 15, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1218140
- Company Name: Advarra IRB
- Inspection Date: 2023-09-15
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs

## Related Documents

- [FDA Inspection 1218140 - 2023-09-15](https://www.keypedia.com/records/fda_inspections/advarra-irb/7a689943-f26b-4ce2-8b25-7d6d96b1c20f)
- [FDA Inspection 1218140 - 2023-09-15](https://www.keypedia.com/records/fda_inspections/advarra-irb/1dcb8034-539c-43ac-ad55-9dc953a848c1)
- [FDA Inspection 1144543 - 2021-05-27](https://www.keypedia.com/records/fda_inspections/advarra-irb/b6407738-2768-4dd0-990d-642d6cd4c1ef)
- [FDA Inspection 1144543 - 2021-05-27](https://www.keypedia.com/records/fda_inspections/advarra-irb/8e6bad1b-a876-4dd4-ae10-1980205b41dc)
- [FDA Inspection 1144543 - 2021-05-27](https://www.keypedia.com/records/fda_inspections/advarra-irb/501d63b7-8fa7-435d-8209-c6b7e56e1a2c)

Company: https://www.keypedia.com/companies/advarra-irb/d136cac1-c58c-409f-ae40-fe053d284edb